Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 15Thoracic 4Gastrointestinal 4Plasma cell 3Lymphoid 3Head & Neck 3Sarcoma 2Other solid neoplasm 2Genitourinary 2Tumor-Agnostic 1Other hematologic neoplasm 1Gynecologic 1CNS 1

Conditions

Prostatic Neoplasms 2Motor Activity 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Exercise Therapy × Genitourinary × Clear all
NCT05751434 2026-05-18

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT04556045 2026-05-07

Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer

Case Comprehensive Cancer Center

Phase NA Active not recruiting
80 enrolled
Genitourinary

Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡